Evogene Ltd. Logo

Evogene Ltd.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evogene Ltd. is a computational biology company that aims to revolutionize the development of life-science products. Its proprietary Computational Predictive Biology (CPB) platform integrates artificial intelligence (AI), machine learning, and big data with deep biological knowledge to accelerate and de-risk the discovery and development process. The company's AI-driven tech-engines are used to design novel products based on microbes, small molecules, and genetic elements. Evogene's solutions target the human health, agriculture, and industrial application sectors. The company operates through a model of subsidiary companies, each focusing on a specific commercial field with an exclusive license to its technology.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Evogene Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 16:00
Report Publication Announcement
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 110.4 KB
2025-08-28 16:00
Foreign Filer Report
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 36.6 KB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 2.2 MB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 36.7 KB
2025-08-19 01:00
Foreign Filer Report
Other Report or Announcement
English 122.5 KB
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Foreign Filer Report
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Proxy Solicitation & Information Statement
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN